As of 2:15pm ET
| -0.19 / -6.15%|
The 1 analysts offering 12-month price forecasts for Biocept Inc have a median target of 4.75, with a high estimate of 4.75 and a low estimate of 4.75. The median estimate represents a +63.79% increase from the last price of 2.90.
The current consensus among 1 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.